Scientists developed a prototype two-dose vaccine by combining the Receptor Binding Domain antigen, via conjugation to Diphtheria toxoid.
[NPJ Vaccines]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.